Last updated: 2026-09-05 22:36:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Simulations Plus, Inc. (SLP) operates in the SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN sector and is listed on NASDAQ. The stock is currently priced at $18.43, with a market capitalization of $372.74M and a P/E ratio of 45.96. Over the past 52 weeks, its price has ranged from $11.09 to $21.01. This page covers its latest market performance, valuation, price trends and company information.
$372.74M | |
$18.44 | |
$90.92 | |
$0.01 | |
$18.42 | |
71.69K | |
-- | |
45.96 | |
$21.01 | |
$11.09 | |
-- | |
-- |
Simulations Plus, Inc. (SLP) last closed at $18.42 as of 2026-09-04 23:31:00, unchanged from the previous close of $18.42.
During the latest regular trading session, SLP traded between $0.01 and $90.92, with a volume of 71.69K shares. The closing price was near the lower end and near the upper end of its 52-week range.
Over the past seven days, Simulations Plus, Inc. (SLP) moved from $18.39 to $18.43, representing a gain of 0.19% ($0.04).
The stock traded between $18.43 and $18.45 during the period. The latest price is near the lower end of the 7-day range, indicating range-bound.
The average daily volume was 200.58 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 73.9%
SLP is currently trading at $18.43, placing it 73.9% of the way from its 52-week low of $11.09 to its 52-week high of $21.01. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
| Industry | SERVICES-COMPUTER INTEGRATED SYSTEMS DESIGN |
| Employees | 213 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of Simulations Plus, Inc. (SLP) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.